WAYNE, PA, Developer of medical devices for minimally invasive peripheral vascular procedures announced that current investors have exercised their right to invest additional capital. more...
SAN FRANCISCO, CA, Company harnessing the body's antitumor immunity by fine-tuning the tumor microenvironment, announced the closing of an $8 million Series A-1 investment round. more...
LEXINGTON, MA, Privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery has closed a $45.6 million Series B. more...
SALT LAKE CITY, UT, Global leader in the development of dexterous robots for use in unstructured environments, today announced the second closing of its Series A funding round. more...